Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 29, 2022; 98 (13) Patient Page

The Lonely Path to Dementia

Melissa Paretsky
First published March 28, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200234
Melissa Paretsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
The Lonely Path to Dementia
Melissa Paretsky
Neurology Mar 2022, 98 (13) e1406-e1408; DOI: 10.1212/WNL.0000000000200234

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
420

Share

  • Article
  • Info & Disclosures
Loading

Embedded Image

People experience loneliness when their desired social experience does not match their perceived social reality. New research shows that social relationships are important for maintaining good mental health and preventing physical illness and disease, such as dementia.1,2

Dementia occurs when a person is no longer able to complete daily activities due to a decline in mental and physical function. Most people think of dementia as a disease that causes memory problems. It also affects a person's emotional and psychological health.

What Did the Authors Study?

This study looked at the relationship between loneliness and dementia over time. The authors also compared the effects of loneliness to the early signs of dementia.

How Was the Study Done?

To look at the relationship between loneliness and dementia over time, the authors used information collected from the Framingham Heart Study. This study follows people over a long period of time and looks at a variety of health variables. The 2,308 participants in the study were at least 60 years old and did not have dementia when the study began.

The authors measured loneliness by using a single question from a depression survey. It asked how many days respondents felt lonely in a typical week. Respondents were categorized as either lonely (3–7 days) or not lonely (0–2 days).

The authors then assessed dementia with a review panel that included both neurologists and neuropsychologists. The panel looked at test results, telephone interviews with family and caregivers, and medical records.

The authors also studied various brain changes that are typical with dementia. They used MRI to gather pictures of the participants' brains. Brain cells called neurons communicate with each other to carry out the functions of the brain. With dementia, these cells stop communicating, and some die. This is known as brain atrophy. The brain is made up of both white and gray matter. White matter, which has a coating that helps cells communicate with each other, shows some of the earliest changes on MRI with aging and dementia.

There are also cognitive changes (that is, changes to thinking and brain function) that can be observed and measured. The researchers in this study used neuropsychological tests to examine various thinking abilities in the study participants. Dementia was measured using tests of cognitive skills, including memory, visual spatial abilities, and executive functioning. Executive functioning refers to mental functions such as attention, judgment, organization, planning, and decision-making. These skills are commonly affected by dementia.

The researchers also considered genetic signs of dementia. The APOE gene gives the body instructions for how it should carry cholesterol and other fats. The most common types of this gene are ε2, ε3, and ε4. Past studies have found that many people who have Alzheimer disease and related dementia have the APOE ε4 type, or allele, of this gene. Because of this, the authors of this study included APOE ε4 allele status to examine the study participants' genetic vulnerability.

What Did the Study Show?

This study showed a higher risk of dementia in adults who experienced loneliness. Those who felt lonely had a significantly higher risk of dementia over a 10-year span. Specifically, 22% of lonely participants developed dementia (as a comparison, 14% of the overall participants developed dementia). Surprisingly, this risk was tripled for participants who were younger and did not carry a genetic marker (APOE ε4). For individuals who did not develop dementia, loneliness still led to poorer executive function, lower total brain volume, and greater changes in white matter.

Why Does This Study Matter?

Loneliness is common, and is increasing. Studies suggest that between 13% and 43% of older adults reported feeling lonely between 2018 and 2020.1,2 Dementia rates are also increasing. There were 57.4 million people living with dementia globally in 2019, and this is projected to increase to 152 million by 2050.4 Therefore, this is an important study given the increasing numbers of both loneliness and dementia.

Most research linking loneliness and dementia has been limited to studying people at a single point in their lives. This is one of the first studies to look at the relationship between loneliness and dementia over a longer period of time. These results are supported by a recent similar study that found a 40% increased risk of dementia among older adults who reported loneliness.3

This study suggests that there may be actions people can take to prevent dementia. Unlike age and genetics, loneliness is a risk factor for dementia that can be influenced. In addition, the association of loneliness with younger participants points to the importance of screening people for both loneliness and dementia at younger ages.

What Remains Unknown?

It remains unclear whether loneliness is a symptom of developing dementia or if it is part of the cause. It is also unclear why the risk of dementia was greater for younger participants of this study who did not have a genetic risk. Finally, this study's participants were mostly White. Similar research is needed in a more diverse population to find out whether these effects are seen among other groups as well.

About Dementia

What Is Dementia?

Dementia is a decline in a person's memory and thinking that prevents the person from carrying out daily social and work activities. It takes many years and sometimes decades for someone's dementia to progress enough to cause disabling impairment. Because these changes happen slowly, they are often subtle at first. For example, a person might forget things more than usual or have trouble finding the right words to say. Mild cognitive impairment is a term used when these changes do not interfere with a person's ability to complete daily tasks and activities. Later, as memory and more complex cognitive processes worsen and a person is no longer able to complete daily activities, the person is diagnosed with dementia.

What Are the Symptoms?

Cognitive symptoms include changes in memory, language, attention, planning, and organization. Memory is typically one of the first changes that is noticed. People in the early stages of dementia may forget the names of common objects or be unable to remember recent events. Later, they will experience difficulties with more complex attention skills such as organization, judgment, and problem solving. They may not be able to follow step by step instructions or may start missing bill payments. Some may have trouble driving or get lost in familiar locations. Eventually, a person with dementia may experience confusion and disorientation.

There are also emotional symptoms such as anxiety and depression. People may lose interest in activities they used to enjoy, have a hard time making decisions, and withdraw from friends and family. Sleep disturbances are common. Some also experience paranoia, delusions, and aggression.

How Is Dementia Diagnosed?

A medical, neurologic, and neuropsychological evaluation is needed to diagnose dementia. A family history assessment, medication assessment, and a timeline of the changes in cognition and personality will be completed. The medical provider, typically a neurologist, will test the person's mental abilities. The provider will also perform tests to rule out other conditions such as vitamin deficiencies, toxins, and infection that may have symptoms that are similar to what is seen with dementia. Providers may also look for genetic markers and complete brain scans and psychiatric tests. Finally, neuropsychologists can perform comprehensive cognitive tests both at the time the diagnosis is first made and again later on to follow cognitive changes over time.

A formal diagnosis of dementia is made when an individual has 2 or more impairments in cognition that show a clear decline from the previous level of function and that keep the person from carrying out everyday activities.

What Causes Dementia?

Dementia is caused when loss of or damage to brain cells prevents them from communicating effectively with each other. Dementia can result from both irreversible and reversible causes. Examples of irreversible causes include neurodegenerative diseases such as Alzheimer disease. Reversible causes include lifestyle and other factors that can be changed or improved, such as alcohol and drug use, vascular disease, head injury, and dietary deficiencies. Age and genetics are also major risk factors.

What Are the Treatments?

At this time, there is no restorative treatment for dementia. Medications and rehabilitation help individuals with dementia maintain their current levels of function, manage their behavioral symptoms, slow or delay the progression of the disease, and adapt their lifestyles to changes. The home environment should be made safe and there should be a caretaker available. Maintaining a calm home and creating a consistent routine can help with the behavioral and psychological symptoms of dementia. The role of a caregiver can be challenging. There are support groups for caretakers of individuals with dementia.

Prevention

Factors such as age and genetics cannot be changed, but there are reversible causes of dementia that are under a person's control. These include lifestyle choices: maintaining a healthy diet, avoiding excess alcohol and other toxic chemicals, exercising, maintaining good sleep habits, and engaging in activities that keep the mind active, including social activities.

For More Information

Brain & Life

brainandlife.org

American Brain Foundation

americanbrainfoundation.org

Alzheimer's Association

alz.org

Alzheimer's Foundation of America

alzfdn.org

Footnotes

  • Related Article: Association of Loneliness With 10-Year Dementia Risk and Early Markers of Vulnerability for Neurocognitive Decline

    Page e1337

  • © 2022 American Academy of Neurology

References

  1. 1.↵
    1. Salinas J,
    2. Beiser AS,
    3. Samra JK, et al
    . Association of loneliness with 10-year dementia risk and early markers of vulnerability for neurocognitive decline. Neurology. 2022;98(13):e1337-e1348.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Ong AD,
    2. Uchino BN,
    3. Wethington E
    . Loneliness and health in older adults: a mini-review and synthesis. Gerontology. 2016;62(4):442-449.
    OpenUrl
  3. 3.↵
    1. Sutin AR,
    2. Stephan Y,
    3. Luchetti M
    . Loneliness and risk of dementia. L Gerontol B Psychol Sci Soc Sci. 2020;75(7):1414-1422.
    OpenUrl
  4. 4.↵
    1. Nichols E,
    2. Steinmetz JD
    , GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease study. Lancet Public Health. 2022;7(2):e105-e125.
    OpenUrl

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • What Did the Authors Study?
    • How Was the Study Done?
    • What Did the Study Show?
    • Why Does This Study Matter?
    • What Remains Unknown?
    • About Dementia
    • What Is Dementia?
    • What Are the Symptoms?
    • How Is Dementia Diagnosed?
    • What Causes Dementia?
    • What Are the Treatments?
    • Prevention
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • Association of Loneliness With 10-Year Dementia Risk and Early Markers of Vulnerability for Neurocognitive Decline

Topics Discussed

  • Autonomic diseases

Alert Me

  • Alert me when eletters are published
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise